Capecitabine: all 1,069 studies that test it
Page 7 of 11. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- Capecitabine + Bevacizumab in Patients With Recurrent GlioblastomaCompletedNCT02669173Phase 1
- Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and CapecitabineCompletedNCT02648425Phase 1
- Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal CarcinomaStatus unknownNCT02621970Phase 3
- A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal CancerCompletedNCT02608073Phase 2
- The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal ChemoradiotherapyStatus unknownNCT02604615Phase 3
- Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent ChemoradiotherapyStatus unknownNCT02603159Phase 3
- Capecitabine in Metastatic Breast and GI CancersStatus unknownNCT02595320Phase 2
- A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon CancerCompletedNCT02581423Phase 4
- A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver CancerCompletedNCT02576964Phase 2
- A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal CancerCompletedNCT02567331Phase 4
- A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT02565641Phase 2
- A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric CancerCompletedNCT02563054Phase 3
- A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric CancerCompletedNCT02560974Phase 3
- Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract CancerCompletedNCT02558959Phase 2
- Phase II Study for Solid Metastatic TumorsCompletedNCT02474186Phase 2
- Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal CarcinomaCompletedNCT02460419Phase 3
- Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary CancerCompletedNCT02451553Phase 1
- Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer PatientsStatus unknownNCT02415829Phase 2
- Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer PatientsCompletedNCT02414009Phase 2
- Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular CarcinomaStatus unknownNCT02403544Phase 1
- Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT02394535Phase 1
- Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver MetastasisStatus unknownNCT02380131Phase 4
- Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal CancersStatus unknownNCT02371304Phase 3
- OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic AdenocarcinomaCompletedNCT02368860Phase 1
- Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal CarcinomaCompletedNCT02360501Phase 2
- Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours StudyCompletedNCT02358356Phase 2
- XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based ChemotherapyStatus unknownNCT02350686Phase 2
- Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal CancerStatus unknownNCT02316535Phase 3
- Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric CancerStatus unknownNCT02289547Phase 3
- Low Dose Metronomic Poly-chemotherapy for Metastatic CRCCompletedNCT02280694Phase 2
- Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal CancerCompletedNCT02271464Phase 2
- IMRT-SIB and Capecitabine in Preoperative Rectal Cancer TreatmentStatus unknownNCT02268006Phase 2
- Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast CancerCompletedNCT02253459Phase 3
- Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With BevacizumabCompletedNCT02248571Phase 4
- Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).CompletedNCT02210364Phase 1
- Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal CancerStatus unknownNCT02137356Phase 1
- Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRMSuspendedNCT02121405Phase 3
- Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast CancerStatus unknownNCT02115152Phase 2
- Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCCCompletedNCT02089633Phase 2
- PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASESCompletedNCT02086656Phase 2
- Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal CancerWithdrawnNCT02085005Phase 2
- A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal CancerWithdrawnNCT02079220Phase 2
- Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal CancerStatus unknownNCT02068131Phase 2
- Xeloda Maintenance Versus BSC in Metastatic Colorectal CancerTerminatedNCT02060669Phase 3
- Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological MarkerStatus unknownNCT02043821Not applicable
- The Maintenance Therapy of Capecitabine of Advanced Gastric CancerStatus unknownNCT02038621Phase 2
- Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast CancerStatus unknownNCT02028494Not applicable
- Maintenance Treatment With Capecitabine in Colorectal Cancer PatientsStatus unknownNCT02027363Phase 2
- A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid TumorsCompletedNCT02025803Phase 1
- A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast CancerCompletedNCT02025192Phase 1
- Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous CancerStatus unknownNCT02025036Phase 3
- Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2CompletedNCT02024009Phase 1/2
- Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative ManagementActive, not recruitingNCT02008656Phase 2
- MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerStatus unknownNCT02007148Phase 2
- Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric CancerCompletedNCT02004769Phase 2
- Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerCompletedNCT01969032Phase 2
- A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric CancerTerminatedNCT01967875Phase 2
- Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver MetastasisStatus unknownNCT01962376Phase 4
- A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.CompletedNCT01941966Phase 2
- Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast CancerCompletedNCT01941771Phase 2
- Colon Neoadjuvant FOLFOXIRI StudyActive, not recruitingNCT01941641Phase 2
- 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast CancerCompletedNCT01935492Phase 3
- Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerStatus unknownNCT01924078Phase 2
- Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic CancerCompletedNCT01918644Phase 1
- Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon CancerCompletedNCT01918527Phase 3
- Preoperative Valproic Acid and Radiation Therapy for Rectal CancerStatus unknownNCT01898104Phase 1/2
- Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast CancerCompletedNCT01891227Phase 2
- Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal CancerStatus unknownNCT01880658Phase 2
- A Bioequivalence Study of Capecitabine TabletsCompletedNCT01846650Phase 1
- Study to Compare Cardiovascular Side Effects of Teysuno Versus CapecitabineCompletedNCT01845337Phase 2
- Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersCompletedNCT01843725Phase 1
- Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal CanalTerminatedNCT01843452Phase 2
- XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of StomachStatus unknownNCT01798251Phase 2
- Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS MetastasisCompletedNCT01783756Phase 1/2
- Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma ProtocolTerminatedNCT01760252Phase 2
- Chemoradiotherapy for Patients With Oligometastatic Colorectal CancerTerminatedNCT01759238Phase 2
- A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction CancerCompletedNCT01748773Phase 2
- A Phase I-II Study of PAXG in Stage III-IV Pancreatic AdenocarcinomaCompletedNCT01730222Phase 1/2
- Cetuximab for Elderly Patients With mCRCTerminatedNCT01718808Phase 2
- Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal CancerStatus unknownNCT01716949Phase 1/2
- A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal CancerCompletedNCT01710592Phase 2
- Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the TherapeuticCompletedNCT01703910Phase 2
- Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaTerminatedNCT01668680Phase 2
- Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric CancerTerminatedNCT01665274Phase 2
- Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast CancerStatus unknownNCT01662128Phase 2/3
- "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"Status unknownNCT01641406Phase 2
- Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal TumorsCompletedNCT01640665Phase 1
- A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal AdenocarcinomaCompletedNCT01634685Phase 1
- A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal CancerCompletedNCT01589419Phase 1
- A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or TaxanesCompletedNCT01589159Phase 2
- Study of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasCompletedNCT01572324Phase 2
- Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic AdenocarcinomaCompletedNCT01558869Phase 2
- Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma StudyTerminatedNCT01558011Phase 2
- Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal CancerCompletedNCT01554969Phase 1
- Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal AdenocarcinomaStatus unknownNCT01552967Phase 2
- Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapyStatus unknownNCT01549795Not applicable
- Second Line Therapy in Advanced Biliary Tract CancerCompletedNCT01530503Phase 2
- A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric CancerCompletedNCT01517009Phase 2
- Perioperative Chemotherapy for Potentially Resectable Gastric CancerCompletedNCT01516944Phase 2/3
- Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)PositiveCompletedNCT01503983Phase 2